C
Cyclacel Pharmaceuticals D
D
CYCCP
5.68000
USD
-0.22
(-3.73%)
مغلق
حجم التداول
8
الربح لكل سهم
0
العائد الربحي
2.63
P/E
0
حجم السوق
1,904,351
العنوان: Cyclacel Pharmaceuticals
القطاع: Healthcare
الصناعة: Biotechnology
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib. The company derives its revenue from United Kingdoms.